Author

Yu Qiao

Observed name: Y. Qiao

Institution: Institute of Cancer Research

Observed institution: Institute of Cancer Research

ORCID: 0009-0002-3615-0177

Observed ORCID: 0009-0002-3615-0177

OpenAlex ID: A5123784094

International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR

2026 · Emily Alger, Olalekan Lee Aiyegbusi, et al. · Journal of Clinical Oncology · 11

A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)

2026 · Emily Alger, Antoine Regnault, et al. · The Lancet Oncology · 2

127MO A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials: OPTIMISE-AR

2026 · E.L. Alger, A. Regnault, et al. · ESMO Open

Works count: 3

Citation count: 13

H-index: 2

I10-index: 1